PPARG and breast carcinoma: Ligand-induced PPARγ activation can induce apoptosis in breast [13], [20], [25], [26], prostate [23] and non-small cell lung cancer [24], and PPARγ ligand activation is reported to inhibit breast cancer cell invasion and metastasis [27], [28].